Announced Fri, 26 Jun · 12:20 IST
Trading window closure from 1 July 2026 ahead of Q1 results
Compliance View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.6%1-day move
₹2366.00
prior close
₹2347.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.4+1.7+1.7+1.2+3.6+2.7+1.8+1.7+1.5+1.9+5.6———
Up moveDown movePending
AI summary
GlaxoSmithKline Pharmaceuticals has closed its trading window from Wednesday, 1 July 2026 until 48 hours after the declaration of unaudited financial results for Q1 ending 30 June 2026. This is a routine compliance measure under SEBI insider trading regulations. During this period, directors, KMPs and connected persons cannot trade in company shares. The board meeting date for results will be announced separately.
Likely market impact
Insiders barred from trading shares during this window. Stock may see movement around the upcoming Q1 results date, which is yet to be announced.